Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat

Dr. Reddy's Laboratories Limited (RDY) reported first-quarter fiscal 2025 earnings of $1 per American Depositary Share (ADS), which missed the Zacks Consensus Estimate of $1.10 per ADS. The company reported earnings of $1.01 per ADS in the year-ago quarter. Quarter in Detail Shares of Dr. Reddy's have gained 16.7% year to date compared with the industry's 14.5% growth. Dr. Reddy's reports revenues under three segments: Global Generics, Pharmaceutical Services & Active Ingredients (PSAI) and Others. As of Ju ...